[1]
“Frequency of Hypocalcaemia in Cancer Patients Receiving Zoledronic Acid for Bone Metastasis”, IJBR, vol. 3, no. 2, pp. 235–238, Feb. 2025, doi: 10.70749/ijbr.v3i2.593.